New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria
- 31 January 1992
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (1), 73-80
- https://doi.org/10.1016/0732-8893(92)90059-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 1992
- Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalisDiagnostic Microbiology and Infectious Disease, 1989
- Optimal cefotaxime dosing for gram-negative bacteremia: Effective trough serum bactericidal titer and drug concentrations 8 and 12 hr after 1- or 2-G infusionsDiagnostic Microbiology and Infectious Disease, 1989
- Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides speciesDiagnostic Microbiology and Infectious Disease, 1989
- Pathogens causing nosocomial infections preliminary data from the national nosocomial infections surveillance systemAntimicrobic Newsletter, 1988
- Influence of third-generation cephalosporins on aerobic intestinal floraJournal of Antimicrobial Chemotherapy, 1984
- Clinical Pharmacokinetics of Cefotaxime in Patients with Normal and Reduced Renal FunctionClinical Infectious Diseases, 1982
- CefoperazoneDrugs, 1981
- Metabolism of cefotaxime in animals and manJournal of Antimicrobial Chemotherapy, 1980
- Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and CefoxitinAntimicrobial Agents and Chemotherapy, 1978